Immune OTC Stock Market Value

IMUN -  USA Stock  

USD 2.30  0.60  20.69%

Immune Therapeutics' market value is the price at which a share of Immune Therapeutics stock trades on a public exchange. It measures the collective expectations of Immune Therapeutics investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Immune Therapeutics and determine expected loss or profit from investing in Immune Therapeutics over a given investment horizon. Please see Immune Therapeutics Hype Analysis, Immune Therapeutics Correlation, Immune Therapeutics Valuation, Immune Therapeutics Volatility, as well as analyze Immune Therapeutics Alpha and Beta and Immune Therapeutics Performance.
Symbol
Backtest


The market value of Immune Therapeutics is measured differently than its book value, which is the value of Immune that is recorded on the company's balance sheet. Investors also form their own opinion of Immune Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Immune Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immune Therapeutics' market value can be influenced by many factors that don't directly affect Immune Therapeutics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immune Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Immune Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immune Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Immune Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immune Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immune Therapeutics.
0.00
09/23/2021
No Change 0.00  0.0 
In 30 days
10/23/2021
0.00
If you would invest  0.00  in Immune Therapeutics on September 23, 2021 and sell it all today you would earn a total of 0.00 from holding Immune Therapeutics or generate 0.0% return on investment in Immune Therapeutics over 30 days. Immune Therapeutics is related to or competes with Biontech, Moderna, and Regeneron Pharmaceuticals. Immune Therapeutics, Inc. focuses on the development, approval, and commercialization of pharmaceutical products

Immune Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immune Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immune Therapeutics upside and downside potential and time the market with a certain degree of confidence.

Immune Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Immune Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immune Therapeutics' standard deviation. In reality, there are many statistical measures that can use Immune Therapeutics historical prices to predict the future Immune Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Immune Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Immune Therapeutics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.142.8615.14
Details
Intrinsic
Valuation
LowReal ValueHigh
0.122.4114.69
Details
Naive
Forecast
LowNext ValueHigh
0.052.5314.81
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.032.833.64
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immune Therapeutics. Your research has to be compared to or analyzed against Immune Therapeutics' peers to derive any actionable benefits. When done correctly, Immune Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Immune Therapeutics.

Immune Therapeutics Backtested Returns

We consider Immune Therapeutics extremely dangerous. Immune Therapeutics holds Efficiency (Sharpe) Ratio of 0.015, which attests that the entity had 0.015% of return per unit of risk over the last 3 months. Our standpoint towards determining the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Immune Therapeutics, which you can use to evaluate the future volatility of the firm. Please check out Immune Therapeutics Risk Adjusted Performance of 0.0146, market risk adjusted performance of 0.083, and Downside Deviation of 11.98 to validate if the risk estimate we provide is consistent with the expected return of 0.18%.
Immune Therapeutics has performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.0736, which attests to a somewhat significant risk relative to the market. Let's try to break down what Immune's beta means in this case. Immune Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Immune Therapeutics is expected to follow. Although it is extremely important to respect Immune Therapeutics current price history, it is better to be realistic regarding the information on equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Immune Therapeutics technical indicators, you can presently evaluate if the expected return of 0.18% will be sustainable into the future. Immune Therapeutics right now retains a risk of 12.28%. Please check out Immune Therapeutics semi variance, and the relationship between the treynor ratio and daily balance of power to decide if Immune Therapeutics will be following its current trending patterns.
AdviceVolatility TrendExposureCorrelations

Auto-correlation

    
   0.05   

Virtually no predictability

Immune Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Immune Therapeutics time series from 23rd of September 2021 to 8th of October 2021 and 8th of October 2021 to 23rd of October 2021. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immune Therapeutics price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Immune Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient0.05
Spearman Rank Test0.13
Residual Average0.0
Price Variance0.08

Immune Therapeutics lagged returns against current returns

Autocorrelation, which is Immune Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immune Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Immune Therapeutics returns to help us make a trade decision. For example, suppose you find that Immune Therapeutics otc stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 
Share
      Timeline 

Immune Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immune Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immune Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immune Therapeutics otc stock over time.
 Current vs Lagged Prices 
Share
      Timeline 

Immune Therapeutics Lagged Returns

When evaluating Immune Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immune Therapeutics otc stock have on its future price. Immune Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immune Therapeutics autocorrelation shows the relationship between Immune Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Immune Therapeutics.
 Regressed Prices 
Share
      Timeline 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immune Therapeutics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immune Therapeutics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Immune Therapeutics Hype Analysis, Immune Therapeutics Correlation, Immune Therapeutics Valuation, Immune Therapeutics Volatility, as well as analyze Immune Therapeutics Alpha and Beta and Immune Therapeutics Performance. Note that the Immune Therapeutics information on this page should be used as a complementary analysis to other Immune Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Immune OTC Stock analysis

When running Immune Therapeutics price analysis, check to measure Immune Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immune Therapeutics is operating at the current time. Most of Immune Therapeutics' value examination focuses on studying past and present price action to predict the probability of Immune Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immune Therapeutics' price. Additionally, you may evaluate how the addition of Immune Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Immune Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immune Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immune Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...